Skip to main content
Premium Trial:

Request an Annual Quote

Cellth Systems Licenses CTC Technology From University of Maryland

NEW YORK (GenomeWeb) – The University of Maryland, Baltimore and the University of Maryland, College Park have granted molecular diagnostics firm Cellth Systems an exclusive license to commercially develop a cell-tethering technology that allows for real-time analysis of circulating tumor cells.

Cellth also said today that TEDCO has awarded it $150,000 through the Maryland Innovation Initiative program, which will help advance the device toward commercialization.

The technology licensed to Cellth allows researchers to quantify phenotypic changes in CTCs in real time as they are exposed to a battery of chemotherapeutic drugs, Philip Robilotto, chief commercialization officer of the UM tech transfer initiative UM Ventures, said in a statement.

The technology allows for "immediate, detailed, quantitative, real-time examination," added Stuart Martin, co-inventor of the platform and a professor in the departments of physiology and oncology at the University of Maryland School of Medicine. "There is no need for cells to grow or express proteins, avoiding the traditional weeks- to months-long cell growth process, and yielding a drug-response study within an hour."

Additional terms of the agreement were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.